Tang, W. H. Wilson https://orcid.org/0000-0002-8335-735X
DiDonato, Joseph A.
Allayee, Hooman
Hazen, Stanley L. https://orcid.org/0000-0001-7124-6639
Article History
Received: 4 April 2024
Accepted: 30 July 2024
First Online: 5 September 2024
Competing interests
: S.L.H. reports being named as a co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. S.L.H. also reports having received royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland Heart Lab, a fully owned subsidiary of Quest Diagnostics, and Procter & Gamble. S.L.H. is a paid consultant for Zehna Therapeutics and Proctor & Gamble, and has received research funding from Zehna Therapeutics, Proctor & Gamble, Pfizer and Roche Diagnostics. W.H.W.T. has served as a consultant for Sequana Medical, Cardiol Therapeutics, Genomics plc, Zehna Therapeutics, WhiteSwell, Boston Scientific, CardiaTec Biosciences, Intellia Therapeutics, Bristol Myers Squibb, Alleviant Medical, Alexion Pharmaceuticals, Salubris Biotherapeutics and BioCardia, and has received honoraria from Springer, Belvoir Media Group and the American Board of Internal Medicine. All other authors declare no competing interests.